Ed after they had received counseling and an explanation of the study. Only participants who gave written informed consent were included in this study. For minors and Tubastatin A children, written informed consent was obtained from the next of kin. The National SC 1 supplier Ethics Committee of the Ministry of Health of Madagascar approved the study (Authorization No. 038-SANPF/ CAB, February 20th 2004).classified positive by microscopy, with confirmation by culture on Lowenstein-Jensen medium. The household contacts (HC) of the included IC were visited at home by the study physicians and asked to participate in the study. They were included if they were at least one year old and had been living in the same house as 
the IC for at least six months. The subjects (or their legal guardians, for children) were informed about the study, their consent was then sought and they were interviewed and examined. Only subjects who agreed to undergo an HIV test, after counseling (where appropriate), and who had given informed consent were included in the study. For every TB index case, two community controls (CC) were selected. These controls were healthy volunteers from the dispensary of the Pasteur Institute of Madagascar, matched for age and sex with two HC. In total, we recruited 163 HIV-seronegative subjects: 25 IC, 88 HC and 50 CC. HC and CC had no TB symptoms and a chest Xray on inclusion revealed no evidence of TB. Contacts were regularly monitored, at three month intervals, for up to two years after inclusion, to check for the development of TB symptoms. For all subjects, epidemiological, clinical and bacteriological data were recorded prospectively on individual record forms. Blood samples were collected on inclusion in the study and at the end of eight months of anti-TB treatment for the IC. For HC and CC, blood samples were collected on inclusion and three months after inclusion.Blood tests and white blood cell count differencesVenous blood samples were collected into EDTA-coated Vacutainer tubes and stored at room temperature until analysis. White blood cell (WBC) count was determined with an automated ABX Pentra 120 Retic hematological analyzer (ABX, Montpellier, France). A biologist independently validated the assays.Study site and subjectsAdult TB patients with a recent diagnosis based on a smear positive for acid-fast bacilli (AFB) (index cases [IC], over 15 years of age) were recruited at the principal anti-tuberculosis center in Antananarivo. Positivity was defined as two sputum samplesApoptosis-Related Gene Expression in TuberculosisTable 2. Characteristics of the cohorts recruited for the study.Cohort No. individuals Mean age, years [range] Sex M F TST at inclusion Negative 5?4 mm 15 mm ND BCG vaccination Yes No ND PPD ELISPOT Negative ( ) Positive ( ) ND ESAT-6 ELISPOT Negative ( ) Positive ( ) NDIC 23 32.48 [17?0] 10hHC 70 21.94 [4?8] 33sHC 10 18.1 [5?7] 5CC 46 22.35 [5?0] 21electrophoresis gels and by quantification with a NanoDrop 1000 (Thermo Scientific). All samples were treated with RNaseFree DNAse (Qiagen) according to the manufacturer instructions before reverse transcription. We then generated cDNA from 300 ng of total RNA per sample, with the Omniscript RT kit (Qiagen) and oligo (dT) primers, according to the manufacturer’s instructions. The cDNA aliquots were stored at 280uC until use.Quantification of the expression of apoptosis-associated genes by RT-qPCRWe assessed the expression of the TNFR1, TNFR2, FLICE and FLIPs genes, by carrying out R.Ed after they had received counseling and an explanation of the study. Only participants who gave written informed consent were included in this study. For minors and children, written informed consent was obtained from the next of kin. The National Ethics Committee of the Ministry of Health of Madagascar approved the study (Authorization No. 038-SANPF/ CAB, February 20th 2004).classified positive by microscopy, with confirmation by culture on Lowenstein-Jensen medium. The household contacts (HC) of the included IC were visited at home by the study physicians and asked to participate in the study. They were included if they were at least one year old and had been living in the same house as the IC for at least six months. The subjects (or their legal 
guardians, for children) were informed about the study, their consent was then sought and they were interviewed and examined. Only subjects who agreed to undergo an HIV test, after counseling (where appropriate), and who had given informed consent were included in the study. For every TB index case, two community controls (CC) were selected. These controls were healthy volunteers from the dispensary of the Pasteur Institute of Madagascar, matched for age and sex with two HC. In total, we recruited 163 HIV-seronegative subjects: 25 IC, 88 HC and 50 CC. HC and CC had no TB symptoms and a chest Xray on inclusion revealed no evidence of TB. Contacts were regularly monitored, at three month intervals, for up to two years after inclusion, to check for the development of TB symptoms. For all subjects, epidemiological, clinical and bacteriological data were recorded prospectively on individual record forms. Blood samples were collected on inclusion in the study and at the end of eight months of anti-TB treatment for the IC. For HC and CC, blood samples were collected on inclusion and three months after inclusion.Blood tests and white blood cell count differencesVenous blood samples were collected into EDTA-coated Vacutainer tubes and stored at room temperature until analysis. White blood cell (WBC) count was determined with an automated ABX Pentra 120 Retic hematological analyzer (ABX, Montpellier, France). A biologist independently validated the assays.Study site and subjectsAdult TB patients with a recent diagnosis based on a smear positive for acid-fast bacilli (AFB) (index cases [IC], over 15 years of age) were recruited at the principal anti-tuberculosis center in Antananarivo. Positivity was defined as two sputum samplesApoptosis-Related Gene Expression in TuberculosisTable 2. Characteristics of the cohorts recruited for the study.Cohort No. individuals Mean age, years [range] Sex M F TST at inclusion Negative 5?4 mm 15 mm ND BCG vaccination Yes No ND PPD ELISPOT Negative ( ) Positive ( ) ND ESAT-6 ELISPOT Negative ( ) Positive ( ) NDIC 23 32.48 [17?0] 10hHC 70 21.94 [4?8] 33sHC 10 18.1 [5?7] 5CC 46 22.35 [5?0] 21electrophoresis gels and by quantification with a NanoDrop 1000 (Thermo Scientific). All samples were treated with RNaseFree DNAse (Qiagen) according to the manufacturer instructions before reverse transcription. We then generated cDNA from 300 ng of total RNA per sample, with the Omniscript RT kit (Qiagen) and oligo (dT) primers, according to the manufacturer’s instructions. The cDNA aliquots were stored at 280uC until use.Quantification of the expression of apoptosis-associated genes by RT-qPCRWe assessed the expression of the TNFR1, TNFR2, FLICE and FLIPs genes, by carrying out R.
